Noozhawk.com delivers local breaking news, local sports, schools, nonprofits, obituaries, business, arts and entertainment, calendar, local opinions and more.
Noozhawk.com delivers local breaking news, local sports, schools, nonprofits, obituaries, business, arts and entertainment, calendar, local opinions and more.
Photo by Getty Images
A new randomized study could reduce the morbidity and mortality associated with COVID-19 and streamline clinical research at Yale. The study will enroll 466 patients across five different Yale New Haven Hospital sites to identify a potential COVID-19 treatment.
Led by Alexandra Lansky, MD, a professor of medicine and director of the Yale Cardiovascular Research Group (YCRG), the COLSTAT clinical trial (Colchicine/Statin for the Prevention of COVID-19 Complications) will combine two widely available medications to reduce complications in infected patients. Both have been in use for decades and have no adverse effects in patients with COVID-19.